Pathogenesis and prognosis of thrombotic microangiopathy
- 1 June 2007
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 11 (2), 107-114
- https://doi.org/10.1007/s10157-007-0466-7
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006
- A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersKidney International, 2006
- The molecular biology of thrombotic microangiopathyKidney International, 2006
- Clinical Outcome of Thrombotic Microangiopathy after Living-Donor Liver Transplantation Treated with Plasma Exchange TherapyClinical Journal of the American Society of Nephrology, 2006
- Current Concepts in Thrombotic Thrombocytopenic PurpuraAnnual Review of Medicine, 2006
- Blood pressure in the long-term follow-up of children with hemolytic uremic syndromePediatric Nephrology, 2004
- Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for ApheresisTransfusion, 2003
- Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNature Genetics, 2002
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell RecognitionAmerican Journal of Human Genetics, 2001
- Hemorrhagic Colitis Associated with a RareEscherichia coliSerotypeNew England Journal of Medicine, 1983